{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:46:42Z","timestamp":1789094802825,"version":"build-2803163510"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"Context<\/jats:title>Hyperinsulinism is characterized by dysregulated insulin secretion and is typically associated with reduced fasting tolerance. Long-term hyperinsulinism management includes nutrition and medication to normalize plasma glucose levels. Management of enteral feeds and oral intake is integral to the clinical management strategy in children with hyperinsulinism. A new generation of commercial Food Based Enteral Formulas (FBF) consists of rehydrated food, whole\u2010food protein sources and a mixture of soluble and insoluble fiber.<\/jats:p><\/jats:sec>Objective<\/jats:title>Review the tolerance of a food-based enteral formula for the nutritional management of children with hyperinsulinism.<\/jats:p><\/jats:sec>Methods<\/jats:title>A single-center retrospective case series to explore the dietetic practice of prescribing a commercially available FBF (Compleat\u00ae<\/jats:sup> pediatric, Nestl\u00e9 Health Science) in children with congenital hyperinsulinism (CHI) or postprandial hypoglycemia (PPH). Data were collected on demographics, gastrointestinal symptoms, anthropometrics, percentage glucose management indicators (GMI%) and hypo\/hyperglycemic episodes.<\/jats:p><\/jats:sec>Results<\/jats:title>Data were collected on eight children; six were diagnosed with CHI and two children had PPH. The mean age was 1.4 years (0.4SD). All children had a gastrostomy for enteral nutrition. Six of the eight children were prescribed proton pump inhibitors or stool softeners to manage gastroesophageal reflux and\/or constipation symptoms. Within one month of children being prescribed FBF dietitians documented an 80% improvement in gastrointestinal symptoms. Dexcom glucose data was available for six children. Six months after FBF was prescribed, Dexcon Inc. data reported that five children had an improvement or stable GMI% and all six children had a reduction in hyperglycemic episodes (chi-square =5.8, p-value 0.02). Children prescribed FBF were less likely to require a glucose polymer (Chi-square = 4.9, p-value = 0.02).<\/jats:p><\/jats:sec>Conclusion<\/jats:title>Our retrospective case series suggests that FBF is well tolerated in children with hyperinsulinism and may mitigate gut motility issues associated with hyperinsulinism, especially in relation to gastro-esophageal reflux and constipation symptoms. Furthermore, FBF may help reduce the dependency on glucose polymers and reduce the likelihood of a hyperglycemic episode. A larger sample size and longer follow-up study are necessary to substantiate the potential beneficial impact of FBF\u2019s on glucose control in children with hyperinsulinism.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1574093","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:17:52Z","timestamp":1758773872000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Food-based enteral formula in the nutritional management of children with hyperinsulinism: single center retrospective case series"],"prefix":"10.3389","volume":"16","author":[{"given":"Graeme","family":"O\u2019Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaruby","family":"Cunjamalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30323-0","article-title":"Hyperinsulinaemic hypoglycaemia in children and adults","volume":"5","author":"Shah","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","first-page":"69","article-title":"Congenital hyperinsulinism: diagnosis and treatment update","volume":"9","author":"Demirbilek","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"F98","DOI":"10.1136\/fn.82.2.F98","article-title":"Practical management of hyperinsulinism in infancy","volume":"82","author":"Aynsley-Green","year":"2000","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13023-015-0367-x","article-title":"Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers","volume":"10","author":"Welters","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13023-022-02214-y","article-title":"Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families","volume":"17","author":"Banerjee","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1231043","article-title":"Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus","volume":"14","author":"Shaikh","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2023.2217355","article-title":"Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review","volume":"17","author":"Lionetti","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"104500","DOI":"10.1016\/j.jff.2021.104500","article-title":"Effects of dietary fiber on glycemic control and insulin sensitivity in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"82","author":"Tsitsou","year":"2021","journal-title":"J Funct Foods"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104821","article-title":"Gut microbiota in the pathogenesis and therapeutic approaches of diabetes","volume":"97","author":"Crudele","year":"2023","journal-title":"eBioMedicine"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.10.001","article-title":"Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of prevotella","volume":"22","author":"Kovatcheva-Datchary","year":"2015","journal-title":"Cell Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jpn3.12450","article-title":"Clinical effects of pediatric commercial food-based formulas: A systematic review","volume":"80","author":"Murayi","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional gastrointestinal disorders: history, pathophysiology, clinical features and rome IV","volume":"19","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001889","article-title":"Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the north american society for pediatric gastroenterology, hepatology, and nutrition and the european society for pediatric gastroenterology, hepatology, and nutrition","volume":"66","author":"Rosen","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2019.07.003","article-title":"Continuous glucose monitoring: review of an innovation in diabetes management","volume":"358","author":"Mian","year":"2019","journal-title":"Am J Med Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Danne","year":"2019","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2010.205864","article-title":"Designing the new UK-WHO growth charts to enhance assessment of growth around birth","volume":"97","author":"Cole","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.10812","article-title":"Monitor gastrointestinal tolerance in children who have switched to an \u201centeral formula with food-derived ingredients\u201d: A national, multicenter retrospective chart review (RICIMIX study)","volume":"37","author":"O'Connor","year":"2022","journal-title":"Nutr Clin Pract"},{"key":"B18","doi-asserted-by":"crossref","first-page":"e13374","DOI":"10.1111\/jhn.13374","article-title":"The impact of an enteral formula with food-derived ingredients on dietetic practice at a specialist children\u2019s hospital in the UK: Retrospective study","volume":"38","author":"O\u2019Connor","year":"2025","journal-title":"J Hum Nutr Dietetics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.886552","article-title":"Congenital hyperinsulinism international: A community focused on improving the lives of people living with congenital hyperinsulinism","volume":"13","author":"Raskin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i11.3252","article-title":"Constipation, hard stools, fecal urgency, and incomplete evacuation, but not diarrhea is associated with diabetes and its related factors","volume":"22","author":"Ihana-Sugiyama","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF02369356","article-title":"Hyperinsulinaemia impairs gastrointestinal motility and slows carbohydrate absorption","volume":"38","author":"Eliasson","year":"1995","journal-title":"Diabetologia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"798","DOI":"10.6133\/apjcn.082016.07","article-title":"Efficacy and safety of pectin-supplemented enteral nutrition in intensive care: a randomized controlled trial","volume":"26","author":"Xi","year":"2017","journal-title":"Asia Pac J Clin Nutr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13054-024-05128-2","article-title":"The efficacy of fiber-supplemented enteral nutrition in critically ill patients: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis","volume":"28","author":"Koch","year":"2024","journal-title":"Crit Care"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/39.2.338","article-title":"The contribution of the large intestine to energy supplies in man","volume":"39","author":"McNeil","year":"1984","journal-title":"Am J Clin Nutr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06466-x","article-title":"Gut microbial carbohydrate metabolism contributes to insulin resistance","volume":"621","author":"Takeuchi","year":"2023","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutos.2023.12.002","article-title":"An open-label pilot single-subject study to monitor the impact of a Food-Based enteral formula on faecal short-chain fatty acid concentrations in children admitted to intensive care with sepsis","volume":"53","author":"O'Connor","year":"2024","journal-title":"Clin Nutr Open Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chom.2020.12.012","article-title":"Role of dietary fiber in the recovery of the human gut microbiome and its metabolome","volume":"29","author":"Tanes","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081671","article-title":"Gastro-esophageal reflux in children","volume":"18","author":"Rybak","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B29","unstructured":"British dietetic associations practice toolkit: the use of blended diet with enteral feeding tubes.\n \n 2021"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvac210","article-title":"Performance of the glucose management indicator (GMI) in type 2 diabetes","volume":"69","author":"Fang","year":"2023","journal-title":"Clin Chem"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1574093\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:17:54Z","timestamp":1758773874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1574093\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":30,"alternative-id":["10.3389\/fendo.2025.1574093"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1574093","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"article-number":"1574093"}}